Gelderblom, H., Palmerini, E., Blay, J., Sande, M. V. D., Broto, J. M., Terés, R., Davies, M., Seltzer, E., Veltkamp, S., Tinoco, G. (2025). A phase 3, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of emactuzumab in patients with tenosynovial giant cell tumor (TANGENT).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps11584